Truncated multivariate survival models are proposed for the analysis of data from the South Australian Methadone Program. Injecting drug users may have several entries to and exits from the program. A marginal approach for recurrent events is found to provide a useful and simpli ed basis for modelling the retention of injecting drug users on methadone. The likelihoods and results of tting two forms of truncated survival models are presented, together with recommendations for statistical analysis using S-PLUS. The relative merits of the marginal approach, in this context, and alternative ways of viewing the data are discussed.
Introduction
Survival analysis has profoundly in uenced biomedical research and applied statistics over the past two decades. This eld of statistics involves the study of survival times for a group or groups of individuals, for whom survival time is de ned from a well-de ned initiating event, to a prede ned outcome event or`failure' for each individual. Interest focusses on the distribution of these times and the e ect on survival of any explanatory variables. Analysis is often complicated by incomplete, or censored observations, i.e., the failure event may not have been observed for all individuals at the conclusion of follow-up. In many studies, one type of event or failure is of interest, such as death following a diagnosis of AIDS or cancer, or the development of AIDS following a positive HIV antibody test.
Modern survival analysis dates from the path-breaking work of Cox (1972 Cox ( , 1975 on the proportional hazards model, which laid down a sound theoretical basis for analysis. The literature has since grown enormously, with major advances in both the asymptotic and counting process frameworks. The classical texts are Kalb eisch & Prentice (1980) and Cox & Oakes (1984) which treat the topic primarily from the asymptotic approach. More recently, the texts by Andersen, Borgan, Gill & Keiding (1993) and Fleming & Harrington (1991) provide useful accounts of the counting process approach. Excellent overviews of recent developments in the eld are also to be found in Clayton (1988 Clayton ( , 1994 , Klein & Goel (1992) , Lin (1994) and Kooperberg, Stone & Truong (1995) .
Recently, we have been concerned with analysing data from the South Australian Methadone Program observed over the decade [1981] [1982] [1983] [1984] [1985] [1986] [1987] [1988] [1989] [1990] [1991] . In particular, we have data on 269 injecting drug users who entered the program at least once during this period. If an individual was not seen for a break of two or more weeks, this de ned the end of that program. 113 individuals returned for a second or subsequent program, and of these, 45 entered a third program. We are interested in factors associated with retention on methadone and patterns of individual entries to and exits from subsequent programs.
The data arising from this study may be modelled by multivariate failure time methods, or more particularly, methods for recurrent events. Such data are encountered when each subject under study may experience more than one event or failure; here the events are of the same type. The analysis of multivariate failure time data has a recent substantial history and an on-going debate as to the appropriate way to analyse such data. Clayton (1994) provides an interesting overview of the development of methods based on two streams of overlapping thought, namely Cox's regression model for life tables (1972) and Nelder & Wedderburn's formulation for generalised linear models (1972) . Our interest here lies in the former approach, in particular Cox's proportional hazards regression model. We may, very loosely, treat the individual patterns of entries to and exists from the methadone program as a form of` ltering' (Andersen et al, 1993) , where times on the program coincide with treatment.
Since individual injecting drug users may have repeated programs, we need to consider subject-level e ects which may induce correlation between recurrence times.
Frailty models (Clayton, 1988 (Clayton, , 1994 can account for heterogeneity between subjects by specifying an appropriate parametric distribution for a so-called frailty variable.
A less complex option, which we pursue here, is to model this dependence directly through the covariates, which is particularly appropriate if there is evidence of independence between repeated failure times for each individual. One may also view the methadone survival data as the sum of two types of survival times : times`on' and`o ' methadone; or indeed as longitudinal data with two states. However, we demonstrate in this paper that a marginal approach (see for instance Lin, 1994) to the recurrent event survival data, using truncated survival models, is realistic and appropriate for studying retention on the South Australian Methadone Program.
We begin Section 2 by discussing survival models for recurrent events within the context of the methadone study. Two truncated survival models are proposed, both addressing questions of interest about retention on methadone. We consider a likelihoodbased marginal approach within the Andersen & Gill (1982) framework, and the appropriate partial likelihoods for both models proposed are presented. A brief summary of our exploratory analyses leads the way in Section 3, with notes on how the nal models were obtained. We present the discussion in Section 4, with a note on the results and comments on alternative approaches. S-PLUS commands for implementing the models are set out in the Appendix.
Survival models for recurrent events
A general de nition of survival time for recurrent events is not easy to obtain as it may take many forms, depending on the context. For the marginal approach, survival time (T ik ), is de ned as the time from entry to the study up until the k th recurrence for the i th subject (i = 1; :::; n; k = 1; :::; K), where there are K types of failures in the multivariate case or at most K recurrences of the same failure type.
Within the proportional hazards framework, we are able to derive the marginal distribution for each failure type such that the hazard for the i th individual for the k th failure type is k (t) = 0 (t)e 0 Z ik (t) (1) or k (t) = 0k (t)e 0 Z ik (t) (2) depending upon whether we assume the baseline hazards are the same or di erent (respectively) over the K failure types. 0 (t) and 0k (t) are the baseline hazard functions, Z ik (t) is the covariate vector for the i th individual on the k th program at time t, and is the corresponding vector of regression parameters. We note here that is taken to be the same amongst the marginal models, an assumption justi ed by introducing appropriate type-speci c covariates if necessary.
Assuming that observations within each failure type are independent, partial likelihood functions for models (1) & (2) can be readily obtained. Then, one may rede ne the de nition of survival time and/or the risk-set indicators Y ik (t) in order to re ect the nature of the problem at hand (see Lin, 1994) .
For the methadone data, the failure event is de ned as an exit from the program. A typical case may take the following form: We focus on the modelling of two di erent de nitions of survival time, both truncated, since in each case individuals come under observation only after a certain time since the time origin, here de ned to be the date at rst injecting drug use. Incorporating truncation e ects is a natural way to condition upon the fact that each individual has to have been a user and/or under observation and potentially able to enter a particular program. Assuming that the hazards remain constant over programs, the partial likelihood for model A is :
where ik = I(T ik C ik ) and Y jl (X ik ) = ( 1 jl < X ik X jl 0 otherwise . The log partial likelihood is then
; : (4) (4) is modi ed for model B by replacing X ik in (3) with (X ik ? X i;k?1 ) and de ning the risk set indicator to be Y jl (X ik ? X i;k?1 ) = ( 1 jl ? X j;l?1 < X ik ? X i;k?1 X jl ? X j;l?1 0 otherwise .
We can model hazards that di er for an individual's rst, second and third treatment program (i.e. (2)) with the partial likelihood for model A then being
where
The corresponding log of the partial likelihood is then :
with the previously described modi cations again relevant for model B.
In general, estimates of the standard error of^ may be biased by assuming marginaltype models for analysis in the presence of dependence (i.e repeated programs within individuals) in the data. Robust covariance estimators of^ are available (see Wei, Lin & Weissfeld, 1989) and are readily t in S-PLUS for the truncated models considered here.
We note that individuals who have an incomplete observation on the k th program have no data on the k + 1 th or any subsequent programs; in each case, this is due to the end of follow-up. In our study, incomplete observation on subsequent programs depends on the length of time spent on previous programs, inducing data that is not missing completely at random (see Rubin & Little, 1987 
Prevalent and incident univariate survival models
The three consecutive programs were analysed separately in the rst instance using incident (where time origin is date of rst injecting drug use) and prevalent (where the time origin is date of entry to the program) models. For discussions of such survival models, see Wang, Brookmeyer & Jewell (1993) and Ripley & Solomon (1995) . A complication here is that data on date of rst injecting drug use were missing for 39 individuals. Using Buck's method (see Rubin & Little, 1987, pp. 44-47) and regressing date1stIV on sex and age for the other 239 individuals, the 39 missing values were imputed. The imputed values were very similar in distribution to the non-missing values.
Each survival regression was performed in two stages where a best-tting model of entry characteristics was found, followed by a best-tting model including program
covariates. The purpose of the two-stages was to maintain the`order' of the variables and how they arose. Models were t in S-PLUS using stepwise regression based on the log partial likelihoods.
Kaplan-Meier estimates of the survival functions for each of the prevalent models (P1 -P3) were plotted (see Figure 1 ) and suggested little change in the hazards over programs for the rst year. This observation was supported by the log-rank test which found no signi cant di erences between the survival curves, although there is some suggestion of non-proportionality. Table 1 program for a given individual, whereas the remaining covariates could do so.
In a similar fashion, we t prevalent and incident models for P2 and P3, initially with a simpli ed model containing only entry covariates, plus information from previous programs, as well as those available at entry to P1. However, when we added the program two covariates, few remained signi cant. Similarly, the addition of program three covariates also resulted in few remaining signi cant. The results are set out in Tables 2 and 3 respectively.
Having a higher starting dose of methadone (1STDOSE, mg) was signi cantly associated with retention in the best-tting prevalent and incident models for the second program. The signi cance and e ect of METHCHEM was maintained in both models, while that for URATEOP was maintained only for the incident model. Trends in the other covariates were similar to those in Table 1 , but not statistically signi cant. METHCHEM is again associated with signi cantly better retention on the third program. In the incident model, the time from rst injecting drug use to P1 entry (GAP1) indicates that longer periods between rst injecting drug use and entering the methadone program were associated with poorer retention. As for P2, the e ects of the other covariates were similar but not statistically signi cant.
We note here that maximum dose of methadone was omitted for the purposes of the present analysis. Dosage increased to a maximum before decreasing again, however, the time of maximum dose was not recorded. Moreover, there are di culties in interpreting the e ect of such time-related variables. It is interesting to note that the e ects of the other covariates were little altered by excluding maximum dose, although the goodness-of-t was signi cantly poorer.
Analysis of`gap' times and multivariate truncation models
We examined correlations of the within-individual times spent on programs. All such correlations were typically small, justifying the independence assumption of the marginal approach and the treatment of incomplete observations as missing at random.
For the cohort of individuals who completed three consecutive programs (n=26) the correlations between P1 and P2, P2 and P3, and P1 and P3 are respectively 0.23, 0.14 and 0.11. For the cohort who completed two consecutive programs (n=84) the correlation between P1 and P2 is 0.27; however this correlation reduces to 0.18 with the removal of a single individual who spent almost ve years on P1 and three years on P2.
It is important to analyse in detail the`gap times' between programs as they can be considered to represent a di erent type of time. Kaplan-Meier curves for the times between the date at rst injecting drug use and entry to P1 (i.e., GAP1), P1 exit and P2 entry (i.e., GAP2), and P2 exit and P3 entry (i.e., GAP3) were plotted (see Figure 2 ) and found to have signi cant di erences (P < 0:05). Upon inspection, there was an indication that people tended to have smaller gap times as they progressed to subsequent programs, although GAP2 and GAP3 are very similar. Due to the nature of the heterogeneous gap times, it is important that they be accounted for directly in the modelling process, and this justi es the formulation of the two truncated models de ned in Section 2.
In order to arrive at the`best' model for the data for both types of truncation, an important consideration was whether to t any covariate whose information may change over di erent programs as program-speci c covariates, or as a single covariate
representing the e ects averaged over programs. Most exploratory ttings suggested no bene t in the use of time-dependent or individual program-speci c covariates as e ects and signi cance levels remained relatively consistent over programs.
Regression estimates of covariate e ects for our nal (reduced) multivariate models for both types of truncation are set out in Tables 4 and 5 Overall, these results are consistent with the relatively small observed within-individual correlations and provide further justi cation of the marginal approach. It is worth noting here that if the marginal models are correct then the naive and robust estimates of standard error are asymptotically equivalent (Lin, 1994) .
The year of entry to the methadone program (PENTRY, 1981 (PENTRY, -1984 is the baseline for comparison) is important in the multivariate models, suggesting a signi cantly decreased relative risk as we progress from 1981 to 1991. All remaining covariates displayed in Tables 4 and 5 have similar e ects to the previously detailed prevalent and incident univariate models. We note here that time to a positive Hepatitis C diagnosis (mean 19 years since date1stIV) was also tted as a time-dependent covariate, but was not signi cant. Tables 4 and 5 suggest that the greater the gap between programs (GAPS, days), the poorer the retention on methadone. Due to the heterogeneous nature of the gap times noted above, GAP1, GAP2 and GAP3
were tted as program-speci c covariates. For model A, Table 6 suggests that GAP1
followed by GAP2 contribute most to the overall signi cance of GAPS. Nonetheless, the observed relative risks suggest relatively consistent e ects and similarly for model B. Including the covariates PENTRY and GAPS and incorporating truncation in our models allows us to (indirectly) adjust for observed temporal trends.
A check for non-linearity of the continuous covariates was investigated using martingale residual plots. The plot for gap times for model A is shown in Figure 3 , with similar results observed for model B. The approximate linear t illustrated in Figure   3 provides justi cation for the use of Cox models A and B.
Finally, strati ed models assuming di erent hazards over programs were also tted,
and covariate e ects were found to remain consistent. This nding suggests that for the methadone data, there is no bene t gained by modelling under the assumption of di erent (as opposed to constant) hazards for each program. As noted in Section 2, individuals with an incomplete observation on P1 or P2 have no data for any subsequent programs which consequently violates the assumption of missing completely at random. The proportions of observations censored for P1
Discussion
and P2 remain close to 25% at 66=269 and 29=113 respectively, with an increase to 19=45 for P3. However, with our large dataset, and with individuals monitored for reasonably long periods over the decade, the consequences of such a violation are likely to be minimal. Moreover, we have shown that missing at random is a reasonable assumption for the methadone data, where any dependence may be captured by appropriate modelling of the covariates.
Working as we are within the semi-parametric framework there is no need to specify the underlying hazard in our modelling. However, if we had some knowledge as to the nature of these hazards and were able to classify them as taking a particular form, then it may be possible to work within a parametric framework. Complementary log-log transforms were plotted for each of the three programs and suggested the hazards were monotone decreasing except in the tails where the Weibull assumption underestimates survival (although there is much less information available there anyway). One possibility we are currently considering is to model the data using a multivariate Weibull distribution (Johnson & Kotz, 1972) . However, while a parametric framework for analysis of univariate failure time data may be well understood, the multivariate equivalent is likely to be analytically and computationally complex, and may not simplify matters.
In conclusion, the marginal approach with truncated survival times appears appropriate for the analysis of these data, with consistency obtained for the two types of truncation de ned by models A and B. Nevertheless, it would be interesting to study the alternative approaches outlined in the introduction, as each may shed new light on the methadone data.
APPENDIX
Fitting multivariate survival models in S-PLUS An important development in modern survival analysis has been the representation of the Cox model in the counting process framework of Andersen & Gill (1982) . One motivation for using the counting process approach lies in the complexity involved with deriving large sample asymptotic properties of^ within the partial likelihood framework for more complex survival models. The counting process approach is able to cope with complicated censoring patterns, truncated data, and time-dependent covariates relatively simply, and is readily implemented within S-PLUS as well as SAS. We performed the data analysis in S-PLUS 3.3 (see Therneau, 1994) .
Observations consist of rows of data which contain covariate values Z, a censoring indicator (where 1 = failure event, 0 = censored) and a time interval (Start, Stop] within which this information applies. A stratum indicator is also necessary if we assume that hazards are di erent over strata. A typical display of such information is illustrated below for an injecting drug user entering the program 2556 days after the date of rst injecting drug use (i.e. date1stIV).
After 184 days, they left the program and then re-entered 274 days later. This stay lasted 123 days; they then left for a further 789 days, at which point they re-entered for a third time. Time on the third program was censored after 77 days due to the end of the observation period, 31st The de nition of covariates whose values may change over k programs depends upon whether separate covariates for each program or a single covariate representing the (average) e ect over all programs are appropriate. Average covariate vectors can be set up like the illustrated`Start' vector. Alternatively for the case of program speci c covariates, covariate values may be set at zero, other than those detailing the program they are representing. We note that covariate values set at zero may in fact be set to other values if the marginal assumption does not hold and conditioning upon previous event histories is required. Assuming hazards are di erent over programs (i.e model (2)), we stratify by programs using the stratum indicator Z p+1 say. The S-PLUS command then takes the form :
cox.diff<-coxph(Surv (Start,Stop,Cens) z 1 + + z p + strata(z p+1 ), data = meth) with Start, Stop and Cens taking on the same forms described above as appropriate for model (1). One can also use interaction terms, e.g., (z 1 + z 2 ) strata(program) within the S-PLUS code. Finally, robust covariance estimates are simply obtained by the subcommand`cluster(id)', where this asserts that subjects with the same value of the variable`id' may be correlated. Table 6 : Covariate e ects for program-speci c GAPS within multivariate model A.
